A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07

Clinical trial NCT06194552 · COMPLETED

Trial details

NCT number: NCT06194552
Sponsor: NeuroTherapia, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2022-09-06
Primary completion: 2023-05-31
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.